头颈部透明细胞癌的治疗模式与结局
基于美国国家癌症数据库2004至2015年的268例头颈部透明细胞癌患者回顾性队列研究显示,最常见部位为口腔(44%),多数为低级别(68%)和I至II期(60.6%),5年总生存率为77.6%(95%CI 71.4%-84.2%);多因素分析中仅高级别(HR 5.76)、切缘阳性(HR 4.01)和年龄≥60岁(HR 3.45)与总生存显著相关。
要点
- 头颈部透明细胞癌多见于口腔,多数为低级别和早期,淋巴结及远处转移少见。
- 以手术为基础的治疗后5年总生存率为77.6%(95%CI 71.4%-84.2%)。
- 高级别、切缘阳性和年龄≥60岁与总生存显著相关。
核心结论
- 头颈部透明细胞癌以手术为基础治疗后结局总体良好,病理肿瘤分级与更差生存相关。
- 作者认为常规评估和报告肿瘤分级可能更好地指导医生推荐适当治疗。
研究设计与样本
- 回顾性队列研究,使用美国国家癌症数据库(NCDB)选择2004年至2015年间所有唾液腺透明细胞癌患者。
- 共纳入268例患者,分析人口学、肿瘤特征、治疗和生存,并在治疗患者中进行Cox回归分析。
主要发现
- 中位年龄61岁(范围21-90岁),女性145例(54%)。
- 最常见部位为口腔119例(44%),其次为大唾液腺68例(25%)和口咽41例(15%)。
- 低级别肿瘤81例(68%),I至II期117例(60.6%);淋巴结转移36例(17.5%),远处转移6例(2.4%)。
- 单纯手术134例(50.0%),手术加放疗69例(25.7%);5年总生存率为77.6%(95%CI 71.4%-84.2%)。
- 多因素分析中,高级别肿瘤(HR 5.76;95%CI 1.39-23.85;P=0.02)、切缘阳性(HR 4.01;95%CI 1.20-13.43;P=0.02)和年龄≥60岁(HR 3.45;95%CI 1.39-8.55;P=0.01)与总生存显著相关。
关键数值与推荐
- 单因素分析中,年龄较大、大唾液腺和鼻窦部位、III至IV期、高级别和切缘阳性与更差总生存相关。
- 多因素分析中仅高级别肿瘤(HR 5.76;95%CI 1.39-23.85;P=0.02)、切缘阳性(HR 4.01;95%CI 1.20-13.43;P=0.02)和年龄≥60岁(HR 3.45;95%CI 1.39-8.55;P=0.01)与总生存显著相关。
临床怎么用
- 作者认为,病理肿瘤分级与更差生存相关,常规评估和报告肿瘤分级可能更好地指导医生为这一罕见恶性肿瘤推荐适当治疗。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Clear cell carcinoma (CCC) is a rare salivary gland malignancy, believed to be generally low grade. We investigated CCC epidemiology and clinical behavior, using the National Cancer Database (NCDB). STUDY DESIGN: Retrospective cohort study. SETTING: NCDB. SUBJECTS AND METHODS: All CCCs of the salivary glands were selected between 2004 and 2015. Patient demographics, tumor characteristics, treatments, and survival were analyzed. Cox regression analyses were performed in treated patients. RESULTS: We identified 268 patients with CCC. Median age was 61 (21-90) years. Most were female (145, 54%). The most common site was oral cavity (119, 44%), followed by major salivary glands (68, 25%) and oropharynx (41, 15%). Most tumors were low grade (81, 68%) and stages I to II (117, 60.6%). Nodal (36, 17.5%) and distant metastases (6, 2.4%) were rare. Most were treated by surgery alone (134, 50.0%), followed by surgery and radiotherapy (69, 25.7%). Five-year overall survival (OS) was 77.6% (95% CI, 71.4%-84.2%). In univariate analysis, older age, major salivary gland and sinonasal site, stages III to IV, high grade, and positive margins were associated with worse OS. In multivariate analysis, only high tumor grade (hazard ratio [HR], 5.76; 95% CI, 1.39-23.85; P = .02), positive margins (HR, 4.01; 95% CI, 1.20-13.43; P = .02), and age ≥60 years (HR, 3.45; 95% CI, 1.39-8.55; P = .01) were significantly associated with OS. CONCLUSION: We report the largest series of clear cell carcinomas of the head and neck. Outcomes are generally favorable following surgical-based treatments. In this series, pathologic tumor grade is associated with worse survival. Routine evaluation and reporting of tumor grade might better guide physicians in recommending appropriate treatments in this rare malignancy.
引用
- Oliver J, Wu P, Chang C, et al. Patterns of Care and Outcome of Clear Cell Carcinoma of the Head and Neck. Otolaryngol Head Neck Surg. 2019. PMID: 30857486. doi:10.1177/0194599819835779
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。